Q BioMed Announces Strontium89 Initial Uptake and Momentum in US and EuropeSeveral International Market Authorisations Expected in Q4 Expanding Access to South and Central America and...
Q BioMed Announces Initiation of GMP Production of Novel COVID-19 Therapeutic for Clinical Trial Program COVID-19 clinical trial planned for Q1 2021 supported by Canadian...
Q BioMed Announces Strontium89 will be available as of September 2020 through Named Patient Program for Bone Metastases Pain Palliation in EU and Rest of World Named Patient...
FORT LEE, NJ -- March 19, 2019 -- InvestorsHub NewsWire -- GD Entertainment And Technology (OTC: GDET) (“GDET” or the “Company”) today announced CEO Anil Idnani was...
Four Trending Stocks Leading Biotech Sector on Heels of Latest R&D and Innovative Drug Therapy Advancements Coral Springs, FL -- July 27, 2016 -- InvestorsHub...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -9.9E-5 | -99 | 0.0001 | 0.0001 | 1.0E-6 | 156851 | 9.75E-5 | CS |
4 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 176199 | 9.421E-5 | CS |
12 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 175707 | 9.619E-5 | CS |
26 | -9.9E-5 | -99 | 0.0001 | 0.01 | 1.0E-6 | 110756 | 0.00010274 | CS |
52 | 0 | 0 | 1.0E-6 | 0.0405 | 1.0E-6 | 115380 | 0.00028689 | CS |
156 | -0.451999 | -99.9997787611 | 0.452 | 0.66 | 1.0E-6 | 643738 | 0.03032007 | CS |
260 | -1.679999 | -99.9999404762 | 1.68 | 3.75 | 1.0E-6 | 391691 | 0.18578428 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관